Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis

被引:120
|
作者
Rudolph, B
Saffrich, R
Zwicker, J
Henglein, B
Muller, R
Ansorge, W
Eilers, M
机构
[1] ZENTRUM MOL BIOL HEIDELBERG, D-69120 HEIDELBERG, GERMANY
[2] EUROPEAN MOLEC BIOL LAB, BIOCHEM INSTRUMENTAT PROGRAMME, D-69117 HEIDELBERG, GERMANY
[3] INST MOLEK BIOL & TUMORFORSCH, D-35033 MARBURG, GERMANY
[4] INST CURIE, CNRS, UMR144, F-75005 PARIS, FRANCE
来源
EMBO JOURNAL | 1996年 / 15卷 / 12期
关键词
apoptosis; cell cycle; c-myc; cyclin-dependent kinases;
D O I
10.1002/j.1460-2075.1996.tb00669.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The activation of conditional alleles of Myc induces both cell proliferation and apoptosis in serum-deprived RAT1 fibroblasts, Entry into S phase and apoptosis are both preceded by increased levels of cyclin E- and cyclin D1-dependent kinase activities, To assess which, if any, cellular responses to Myc depend on active cyclin-dependent kinases (cdks), we have microinjected expression plasmids encoding the cdk inhibitors p16, p21 or p27, and have used a specific inhibitor of cdk2, roscovitine. Expression of cyclin A, which starts late in G(1) phase, served as a marker for cell cycle progression. Our data show that active G(1) cyclin/cdk complexes are both necessary and sufficient for induction of cyclin A by Myc. In contrast, neither microinjection of cdk inhibitors nor chemical inhibition of cdk2 affected the ability of Myc to induce apoptosis in serum-starved cells, Further, in isoleucine-deprived cells, Myc induces apoptosis without altering cdk activity, We conclude that Myc acts upstream of cdks in stimulating cell proliferation and also that activation of cdks and induction of apoptosis are largely independent events that occur in response to induction of Myc.
引用
收藏
页码:3065 / 3076
页数:12
相关论文
共 50 条
  • [41] Cyclin-dependent kinases in C. elegans
    Mike Boxem
    Cell Division, 1
  • [42] Identification of inhibitors of cyclin-dependent kinases.
    Veal, JM
    Bramson, N
    Dickerson, S
    Frye, S
    Harris, P
    Hassell, A
    Holmes, B
    Hunter, R
    Kuyper, L
    Lackey, K
    Lovejoy, B
    Luzzio, M
    Montana, V
    Rocque, W
    Shewchuk, L
    Walker, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U1021 - U1022
  • [43] Cyclin-dependent kinases in C. elegans
    Boxem, Mike
    CELL DIVISION, 2006, 1 (1)
  • [44] Cyclin-dependent kinases and rare developmental disorders
    Colas, Pierre
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [45] Cyclin-dependent kinases: Masters of the eukaryotic universe
    Pluta, Aleksandra J.
    Studniarek, Cecilia
    Murphy, Shona
    Norbury, Chris J.
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2024, 15 (01)
  • [46] CYCLINS AND CYCLIN-DEPENDENT KINASES - THEME AND VARIATIONS
    PINES, J
    ADVANCES IN CANCER RESEARCH, VOL 66, 1995, 66 : 181 - 212
  • [47] CYCLINS AND CYCLIN-DEPENDENT KINASES - A BIOCHEMICAL VIEW
    PINES, J
    BIOCHEMICAL JOURNAL, 1995, 308 : 697 - 711
  • [48] Cyclin-dependent kinases and rare developmental disorders
    Pierre Colas
    Orphanet Journal of Rare Diseases, 15
  • [49] INHIBITION OF CYCLIN-DEPENDENT KINASES BY PURINE ANALOGS
    VESELY, J
    HAVLICEK, L
    STRNAD, M
    BLOW, JJ
    DONELLADEANA, A
    PINNA, L
    LETHAM, DS
    KATO, J
    DETIVAUD, L
    LECLERC, S
    MEIJER, L
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 224 (02): : 771 - 786
  • [50] Novel arylazopyrazole inhibitors of cyclin-dependent kinases
    Jorda, Radek
    Schuetznerova, Eva
    Cankar, Petr
    Brychtova, Veronika
    Navratilova, Jana
    Krystof, Vladimir
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (09) : 1975 - 1981